These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

348 related articles for article (PubMed ID: 30115336)

  • 1. Guidelines for the Evaluation and Treatment of Pneumonia.
    Grief SN; Loza JK
    Prim Care; 2018 Sep; 45(3):485-503. PubMed ID: 30115336
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The 2016 Guidelines for Hospital-acquired and Ventilator-associated Pneumonia. A Selection Correction?
    Govindan S; Hyzy RC
    Am J Respir Crit Care Med; 2016 Sep; 194(6):658-60. PubMed ID: 27463241
    [No Abstract]   [Full Text] [Related]  

  • 3. Treatment guidelines and outcomes of hospital-acquired and ventilator-associated pneumonia.
    Torres A; Ferrer M; Badia JR
    Clin Infect Dis; 2010 Aug; 51 Suppl 1():S48-53. PubMed ID: 20597672
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recommendations for treatment of hospital-acquired and ventilator-associated pneumonia: review of recent international guidelines.
    File TM
    Clin Infect Dis; 2010 Aug; 51 Suppl 1():S42-7. PubMed ID: 20597671
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antibiotic resistance in nosocomial respiratory infections.
    Denys GA; Relich RF
    Clin Lab Med; 2014 Jun; 34(2):257-70. PubMed ID: 24856527
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnosis and management of community-acquired pneumonia in adults.
    Watkins RR; Lemonovich TL
    Am Fam Physician; 2011 Jun; 83(11):1299-306. PubMed ID: 21661712
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The impact of guidelines on the outcomes of community-acquired and ventilator-associated pneumonia.
    Ferrer M; Menendez R; Amaro R; Torres A
    Clin Chest Med; 2011 Sep; 32(3):491-505. PubMed ID: 21867818
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Severe community-acquired and hospital-acquired pneumonia].
    Witte L; Drömann D
    Med Klin Intensivmed Notfmed; 2012 Mar; 107(2):151-8; quiz 159. PubMed ID: 22407447
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Management of ventilator-associated pneumonia.
    Diaz E; Ulldemolins M; Lisboa T; Rello J
    Infect Dis Clin North Am; 2009 Sep; 23(3):521-33. PubMed ID: 19665081
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of the 2016 Infectious Diseases Society of America/American Thoracic Society Guideline Criteria for Risk of Multidrug-Resistant Pathogens in Patients with Hospital-acquired and Ventilator-associated Pneumonia in the ICU.
    Ekren PK; Ranzani OT; Ceccato A; Li Bassi G; Muñoz Conejero E; Ferrer M; Niederman MS; Torres A
    Am J Respir Crit Care Med; 2018 Mar; 197(6):826-830. PubMed ID: 28902529
    [No Abstract]   [Full Text] [Related]  

  • 11. Respiratory secretion analyses in the evaluation of ventilator-associated pneumonia: a survey of current practice in pediatric critical care.
    Willson DF; Kirby A; Kicker JS
    Pediatr Crit Care Med; 2014 Oct; 15(8):715-9. PubMed ID: 25068248
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of the duration of antibiotics on clinical events in patients with Pseudomonas aeruginosa ventilator-associated pneumonia: study protocol for a randomized controlled study.
    Bouglé A; Foucrier A; Dupont H; Montravers P; Ouattara A; Kalfon P; Squara P; Simon T; Amour J;
    Trials; 2017 Jan; 18(1):37. PubMed ID: 28114979
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Shorter courses of antibiotic treatment for patients with pneumonia.
    Tanday S
    Lancet Respir Med; 2016 Sep; 4(9):691. PubMed ID: 27460162
    [No Abstract]   [Full Text] [Related]  

  • 14. [Hospital-acquired pneumonia in the light of current recommendations - is there a space for improving patient care?].
    Doubravská L; Uvízl R; Gabrhelík T; Klementová O; Kolář M
    Klin Mikrobiol Infekc Lek; 2018 Mar; 24(1):4-9. PubMed ID: 30016532
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effectiveness of biomarker-based exclusion of ventilator-acquired pneumonia to reduce antibiotic use (VAPrapid-2): study protocol for a randomised controlled trial.
    Hellyer TP; Anderson NH; Parker J; Dark P; Van Den Broeck T; Singh S; McMullan R; Agus AM; Emerson LM; Blackwood B; Gossain S; Walsh TS; Perkins GD; Conway Morris A; McAuley DF; Simpson AJ
    Trials; 2016 Jul; 17(1):318. PubMed ID: 27422026
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ventilator-associated tracheobronchitis and pneumonia: thinking outside the box.
    Craven DE; Hjalmarson KI
    Clin Infect Dis; 2010 Aug; 51 Suppl 1():S59-66. PubMed ID: 20597674
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Considerations unique to pediatrics for clinical trial design in hospital-acquired pneumonia and ventilator-associated pneumonia.
    Bradley JS
    Clin Infect Dis; 2010 Aug; 51 Suppl 1():S136-43. PubMed ID: 20597664
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Nosocomial pneumonia].
    Skřičková J
    Vnitr Lek; 2017; 63(7-8):518-526. PubMed ID: 28933178
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recommended design features of future clinical trials of antibacterial agents for hospital-acquired bacterial pneumonia and ventilator-associated bacterial pneumonia.
    ; ; ; ; Spellberg B; Talbot G
    Clin Infect Dis; 2010 Aug; 51 Suppl 1(Suppl 1):S150-70. PubMed ID: 20597666
    [No Abstract]   [Full Text] [Related]  

  • 20. Challenges and opportunities in the treatment of ventilator-associated pneumonia.
    Schreiber MP; Shorr AF
    Expert Rev Anti Infect Ther; 2017 Jan; 15(1):23-32. PubMed ID: 27771978
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.